UNIPHAR PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.52 EUR | +0.40% |
|
-0.20% | -6.67% |
| 02-27 | Uniphar ups full-year dividend as profit falls but revenue climbs | AN |
| 02-27 | Uniphar Seeks M&A | CI |
ETFs positioned on Uniphar plc
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.02% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,800, the Group is active in Ireland, the United Kingdom, the Benelux, the Nordics, Germany and the United States.
The Company's vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar plc represents a strong combination of scale, growth and profitability.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.52
EUR
Average target price
4.25
EUR
Spread / Average Target
+68.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.67% | 734M | |
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -3.38% | 3.93B | |
| -2.61% | 3.86B |
- Stock Market
- Equities
- UPR Stock
- Funds and ETFs Uniphar plc
